GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,303,000 | -71.8% | 167,760 | -71.8% | 0.01% | -64.0% |
Q1 2022 | $25,915,000 | -26.9% | 594,937 | -26.0% | 0.02% | -16.7% |
Q4 2021 | $35,449,000 | +976.5% | 803,830 | +832.6% | 0.03% | +900.0% |
Q3 2021 | $3,293,000 | -25.6% | 86,189 | -22.5% | 0.00% | 0.0% |
Q2 2021 | $4,429,000 | +17.2% | 111,225 | +5.0% | 0.00% | -25.0% |
Q1 2021 | $3,780,000 | +10.0% | 105,900 | +13.5% | 0.00% | +33.3% |
Q4 2020 | $3,435,000 | -88.3% | 93,345 | -88.1% | 0.00% | -90.0% |
Q3 2020 | $29,436,000 | +427.4% | 782,040 | +471.6% | 0.03% | +328.6% |
Q2 2020 | $5,581,000 | -82.5% | 136,813 | -83.7% | 0.01% | -86.0% |
Q1 2020 | $31,885,000 | +168.0% | 841,523 | +195.6% | 0.05% | +233.3% |
Q1 2019 | $11,897,000 | -43.4% | 284,676 | -48.2% | 0.02% | -48.3% |
Q4 2018 | $21,008,000 | +4019.2% | 549,800 | +4229.1% | 0.03% | +2800.0% |
Q3 2018 | $510,000 | -0.4% | 12,700 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $512,000 | -69.3% | 12,700 | -70.3% | 0.00% | -50.0% |
Q1 2018 | $1,668,000 | -86.9% | 42,700 | -88.1% | 0.00% | -88.2% |
Q4 2017 | $12,723,000 | -47.1% | 358,710 | -39.4% | 0.02% | -54.1% |
Q3 2017 | $24,037,000 | +281.5% | 592,058 | +305.2% | 0.04% | +270.0% |
Q2 2017 | $6,301,000 | +27.2% | 146,116 | +24.3% | 0.01% | +11.1% |
Q1 2017 | $4,955,000 | -92.5% | 117,525 | -93.1% | 0.01% | -92.0% |
Q4 2016 | $65,778,000 | +175.8% | 1,708,090 | +190.5% | 0.11% | +160.5% |
Q1 2016 | $23,847,000 | +372.8% | 588,075 | +370.5% | 0.04% | +437.5% |
Q4 2015 | $5,044,000 | +1170.5% | 125,000 | +1109.7% | 0.01% | +700.0% |
Q3 2015 | $397,000 | -99.5% | 10,333 | -99.5% | 0.00% | -99.2% |
Q2 2015 | $81,632,000 | +1004.2% | 1,959,945 | +1123.5% | 0.12% | +1009.1% |
Q1 2015 | $7,393,000 | -84.0% | 160,198 | -85.2% | 0.01% | -81.4% |
Q4 2014 | $46,272,000 | +87.8% | 1,082,633 | +102.0% | 0.06% | +84.4% |
Q3 2014 | $24,639,000 | +742.6% | 535,979 | +879.2% | 0.03% | +700.0% |
Q1 2014 | $2,924,000 | +180.3% | 54,735 | +162.3% | 0.00% | +100.0% |
Q2 2013 | $1,043,000 | – | 20,870 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |